CV
CapsoVisionยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About CV
Capsovision, Inc.
A commercial stage medical technology company specializing in gastrointestinal endoscopic video imaging equipment
Healthcare Equipment and Supplies
08/01/2005
07/02/2025
NASDAQ Stock Exchange
90
12-31
Common stock
18805 Cox Avenue, Suite 250, Saratoga, CA 95070
--
CapsoVision, Inc., was incorporated under the laws of the State of Delaware on August 1, 2005 as "Capso Vision, Inc." and changed its name to CapsoVision, Inc., on May 31, 2016. The company is a commercial-stage medical technology company that develops advanced imaging and artificial intelligence technologies deployed in their capsule endoscopy solutions to identify gastrointestinal abnormalities for diagnostic and screening purposes.
Company Financials
EPS
CV has released its 2025 Q3 earnings. EPS was reported at -0.17, versus the expected -0.12, missing expectations. The chart below visualizes how CV has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
CV has released its 2025 Q3 earnings report, with revenue of 3.54M, reflecting a YoY change of 19.29%, and net profit of -7.92M, showing a YoY change of -36.71%. The Sankey diagram below clearly presents CV's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
